• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IG20基因表达的敲低使甲状腺癌细胞易于发生凋亡。

Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis.

作者信息

Subramanian Mahesh, Pilli Tania, Bhattacharya Palash, Pacini Furio, Nikiforov Yuri E, Kanteti Prasad V, Prabhakar Bellur S

机构信息

Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

出版信息

J Clin Endocrinol Metab. 2009 Apr;94(4):1467-71. doi: 10.1210/jc.2008-2378. Epub 2009 Feb 3.

DOI:10.1210/jc.2008-2378
PMID:19190106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2682475/
Abstract

AIM

The aim of the study was to investigate the expression and function of the IG20 gene in thyroid cancer cell survival, proliferation, and apoptosis.

METHODS

We determined the expression levels of the major isoforms of IG20 by quantitative RT-PCR in normal and thyroid tumor tissues/cell lines. We evaluated the functional consequence of IG20 knockdown in WRO (follicular carcinoma) and FRO (anaplastic carcinoma) thyroid cancer cell lines by measuring spontaneous, TNFalpha-related apoptosis-inducing ligand (TRAIL), and TNFalpha-induced apoptosis.

RESULTS

The IG20 gene expression levels were higher in benign and malignant thyroid tumors and in WRO and FRO cells relative to normal tissues. Predominantly, MADD and DENN-SV isoforms of IG20 gene were expressed. IG20 knockdown resulted in increased spontaneous, TRAIL-, and TNFalpha-induced apoptosis in WRO, but not FRO, cells. FRO cell resistance to apoptosis is likely due to caspase-8 deficiency.

CONCLUSION

IG20 knockdown renders WRO cells more susceptible to spontaneous, TRAIL-, and TNFalpha-induced apoptosis and thus demonstrates the prosurvival function of the IG20 gene in thyroid cancer. These observations, combined with overexpression of IG20 noted in thyroid tumor tissues, may suggest a potential role in thyroid cancer survival and growth and indicate that IG20 may be targeted either alone or in conjunction with TRAIL or TNFalpha treatment in certain thyroid cancers.

摘要

目的

本研究旨在探讨IG20基因在甲状腺癌细胞存活、增殖和凋亡中的表达及功能。

方法

我们通过定量逆转录聚合酶链反应(RT-PCR)测定正常及甲状腺肿瘤组织/细胞系中IG20主要异构体的表达水平。我们通过检测自发凋亡、肿瘤坏死因子α相关凋亡诱导配体(TRAIL)及肿瘤坏死因子α诱导的凋亡,评估IG20基因敲低对WRO(滤泡癌)和FRO(未分化癌)甲状腺癌细胞系功能的影响。

结果

与正常组织相比,IG20基因在良性和恶性甲状腺肿瘤以及WRO和FRO细胞中的表达水平更高。主要表达的是IG20基因的MADD和DENN-SV异构体。IG20基因敲低导致WRO细胞(而非FRO细胞)的自发凋亡、TRAIL诱导的凋亡及肿瘤坏死因子α诱导的凋亡增加。FRO细胞对凋亡的抗性可能归因于半胱天冬酶-8缺乏。

结论

IG20基因敲低使WRO细胞对自发凋亡、TRAIL诱导的凋亡及肿瘤坏死因子α诱导的凋亡更敏感,从而证明IG20基因在甲状腺癌中的促存活功能。这些观察结果,结合甲状腺肿瘤组织中IG20的过表达,可能提示其在甲状腺癌存活和生长中的潜在作用,并表明在某些甲状腺癌中,IG20可能单独或与TRAIL或肿瘤坏死因子α联合治疗作为靶点。

相似文献

1
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis.IG20基因表达的敲低使甲状腺癌细胞易于发生凋亡。
J Clin Endocrinol Metab. 2009 Apr;94(4):1467-71. doi: 10.1210/jc.2008-2378. Epub 2009 Feb 3.
2
Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.肿瘤坏死因子相关凋亡诱导配体耐药甲状腺癌细胞中 IG20/MADD 的表达下调或去磷酸化使它们易受该配体治疗的影响。
Thyroid. 2013 Jan;23(1):70-8. doi: 10.1089/thy.2012.0155.
3
IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs.与DENN-SV(MADD剪接变体)相反,IG20可抑制肿瘤细胞存活,并增强其对凋亡和抗癌药物的敏感性。
Oncogene. 2004 Feb 5;23(5):1076-87. doi: 10.1038/sj.onc.1207210.
4
MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.IG20基因的MADD/DENN剪接变体对癌细胞存活而言是必要且充分的。
Oncogene. 2006 Oct 12;25(47):6252-61. doi: 10.1038/sj.onc.1209650. Epub 2006 May 8.
5
IG20, a MADD splice variant, increases cell susceptibility to gamma-irradiation and induces soluble mediators that suppress tumor cell growth.IG20是一种MADD剪接变体,它会增加细胞对γ射线照射的敏感性,并诱导出抑制肿瘤细胞生长的可溶性介质。
Cancer Res. 2003 Dec 15;63(24):8768-76.
6
Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3.IG20及其剪接异构体MADD和DENN-SV对肿瘤坏死因子α诱导的细胞凋亡以及半胱天冬酶-8和-3激活的对比作用。
J Biol Chem. 2001 Dec 14;276(50):47202-11. doi: 10.1074/jbc.M104835200. Epub 2001 Sep 27.
7
Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.IG20基因亚型对神经母细胞瘤细胞凋亡及半胱天冬酶-8表达的调控
Cancer Res. 2008 Sep 15;68(18):7352-61. doi: 10.1158/0008-5472.CAN-07-6311.
8
DENN/MADD/IG20 alternative splicing changes and cell death in Alzheimer's disease.阿尔茨海默病中 DENN/MADD/IG20 的可变剪接变化和细胞死亡。
J Mol Neurosci. 2012 Sep;48(1):97-110. doi: 10.1007/s12031-012-9782-9. Epub 2012 Jun 8.
9
MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells.IG20基因的MADD/DENN剪接变体是半胱天冬酶-8激活的负调节因子。敲低可增强TRAIL诱导的癌细胞凋亡。
J Biol Chem. 2007 Apr 20;282(16):11715-21. doi: 10.1074/jbc.M701085200. Epub 2007 Feb 21.
10
MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.MADD是IG20的一种剪接变体,对于丝裂原活化蛋白激酶(MAPK)的激活以及在肿瘤坏死因子-α处理时对抗细胞凋亡起着不可或缺的作用。
J Biol Chem. 2009 May 15;284(20):13533-13541. doi: 10.1074/jbc.M808554200. Epub 2009 Mar 16.

引用本文的文献

1
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets.卵巢癌耐药机制及相关基因靶点
Cancers (Basel). 2022 Dec 18;14(24):6246. doi: 10.3390/cancers14246246.
2
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells.维莫非尼可能克服间变性甲状腺癌细胞中与肿瘤坏死因子相关的凋亡诱导配体(TRAIL)耐药性。
Endocrine. 2020 Jan;67(1):117-123. doi: 10.1007/s12020-019-02028-2. Epub 2019 Aug 3.
3
Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.MADD 表达缺失抑制间变性甲状腺癌的细胞生长和转移。
Cell Death Dis. 2019 Feb 13;10(2):145. doi: 10.1038/s41419-019-1351-5.
4
miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death.微小RNA-181与信号衔接分子DENN/MADD相互作用,并增强肿瘤坏死因子诱导的细胞死亡。
PLoS One. 2017 Mar 21;12(3):e0174368. doi: 10.1371/journal.pone.0174368. eCollection 2017.
5
IG20/MADD plays a critical role in glucose-induced insulin secretion.IG20/MADD在葡萄糖诱导的胰岛素分泌中起关键作用。
Diabetes. 2014 May;63(5):1612-23. doi: 10.2337/db13-0707. Epub 2013 Dec 30.
6
MADD is a downstream target of PTEN in triggering apoptosis.MADD 是 PTEN 触发细胞凋亡的下游靶标。
J Cell Biochem. 2014 Feb;115(2):261-70. doi: 10.1002/jcb.24657.
7
Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells.自噬在乳头状和间变性甲状腺癌细胞对肿瘤坏死因子相关凋亡诱导配体诱导的凋亡的抗性中的作用。
Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3.
8
MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.MADD 敲低增强阿霉素和 TRAIL 诱导的乳腺癌细胞凋亡。
PLoS One. 2013;8(2):e56817. doi: 10.1371/journal.pone.0056817. Epub 2013 Feb 15.
9
Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.肿瘤坏死因子相关凋亡诱导配体耐药甲状腺癌细胞中 IG20/MADD 的表达下调或去磷酸化使它们易受该配体治疗的影响。
Thyroid. 2013 Jan;23(1):70-8. doi: 10.1089/thy.2012.0155.
10
Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.下调 MADD 和 c-FLIP 可克服卵巢癌细胞对 TRAIL 诱导凋亡的抵抗。
Am J Obstet Gynecol. 2011 Oct;205(4):362.e12-25. doi: 10.1016/j.ajog.2011.05.035. Epub 2011 May 27.

本文引用的文献

1
Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.IG20基因亚型对神经母细胞瘤细胞凋亡及半胱天冬酶-8表达的调控
Cancer Res. 2008 Sep 15;68(18):7352-61. doi: 10.1158/0008-5472.CAN-07-6311.
2
Role of IG20 splice variants in TRAIL resistance.IG20剪接变体在TRAIL抗性中的作用。
Clin Cancer Res. 2008 Jan 15;14(2):347-51. doi: 10.1158/1078-0432.CCR-07-0493.
3
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.甲状腺癌的分子遗传学:对诊断、治疗及预后的影响
Expert Rev Mol Diagn. 2008 Jan;8(1):83-95. doi: 10.1586/14737159.8.1.83.
4
MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells.IG20基因的MADD/DENN剪接变体是半胱天冬酶-8激活的负调节因子。敲低可增强TRAIL诱导的癌细胞凋亡。
J Biol Chem. 2007 Apr 20;282(16):11715-21. doi: 10.1074/jbc.M701085200. Epub 2007 Feb 21.
5
Increasing incidence of thyroid cancer in the United States, 1973-2002.1973年至2002年美国甲状腺癌发病率上升情况。
JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164.
6
MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.IG20基因的MADD/DENN剪接变体对癌细胞存活而言是必要且充分的。
Oncogene. 2006 Oct 12;25(47):6252-61. doi: 10.1038/sj.onc.1209650. Epub 2006 May 8.
7
IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.IG20(MADD剪接变体5)是一种促凋亡蛋白,它与DR4/DR5相互作用,并通过增加FADD和半胱天冬酶-8向死亡诱导信号复合物(DISC)的募集来增强TRAIL诱导的细胞凋亡。
Oncogene. 2004 Aug 12;23(36):6083-94. doi: 10.1038/sj.onc.1207804.
8
Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle.反义抑制DENN表达可在体外诱导白血病细胞凋亡,在体内导致肿瘤消退,并改变参与凋亡和细胞周期的基因转录。
Int J Cancer. 2004 Mar;109(1):24-37. doi: 10.1002/ijc.11660.
9
IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs.与DENN-SV(MADD剪接变体)相反,IG20可抑制肿瘤细胞存活,并增强其对凋亡和抗癌药物的敏感性。
Oncogene. 2004 Feb 5;23(5):1076-87. doi: 10.1038/sj.onc.1207210.
10
IG20, a MADD splice variant, increases cell susceptibility to gamma-irradiation and induces soluble mediators that suppress tumor cell growth.IG20是一种MADD剪接变体,它会增加细胞对γ射线照射的敏感性,并诱导出抑制肿瘤细胞生长的可溶性介质。
Cancer Res. 2003 Dec 15;63(24):8768-76.